1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, March 2017 (p3)

Biological Therapy Analysis & Statistics, March 2017 (p3)

24/7 Customer Support

Talk to Ahmad

+44 207 1931 362

Publishers

61-90 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • March 2017
  • by Global Markets Direct

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) – Pipeline Review, ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World
Osteoarthritis - Pipeline Review, H1 2017

Osteoarthritis - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • March 2017
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis – Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • March 2017
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia – Pipeline Review, ...

  • Industries : Therapy, Oncology
  • Countries : United States
Crigler-Najjar Syndrome - Pipeline Review, H1 2017

Crigler-Najjar Syndrome - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • March 2017
  • by Global Markets Direct

Crigler-Najjar Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crigler-Najjar Syndrome – Pipeline Review, H1 2017, provides ...

  • Industries : Biological Therapy
  • Countries : World, United States
Traumatic Brain Injury - Pipeline Review, H1 2017

Traumatic Brain Injury - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • February 2017
  • by Global Markets Direct

Traumatic Brain Injury - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury – Pipeline Review, H1 2017, provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Degenerative Disc Disease - Pipeline Review, H1 2017

Degenerative Disc Disease - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • February 2017
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease – Pipeline Review, H1 2017, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
House Dust Mite Allergy - Pipeline Review, H1 2017

House Dust Mite Allergy - Pipeline Review, H1 2017

  • € 1818
  • Company report
  • February 2017
  • by Global Markets Direct

House Dust Mite Allergy - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy – Pipeline Review, H1 2017, provides ...

  • Industries : OTC, Pharmaceutical, Chronic Disease
  • Countries : Japan, World, North America, United States, Europe
ASIA PACIFIC STEM CELL ASSAY MARKET FORECAST 2017-2025

ASIA PACIFIC STEM CELL ASSAY MARKET FORECAST 2017-2025

  • € 1755
  • Industry report
  • March 2017
  • by Inkwood Research

KEY FINDINGS The Asia Pacific stem cell assay market is expected to grow $640 million by 2025. The market growth is expected at the CAGR of 22.27% in the forecast period. The base year considered for the ...

  • Industries : Biological Therapy
  • Countries : Asia
EUROPE STEM CELL ASSAY MARKET FORECAST 2017-2025

EUROPE STEM CELL ASSAY MARKET FORECAST 2017-2025

  • € 1755
  • Industry report
  • March 2017
  • by Inkwood Research

KEY FINDINGS The Europe stem cell assay market is expected to grow $793 million by 2025. The market growth is expected at the CAGR of 21.49% in the forecast period. The base year considered for the market ...

  • Industries : Biological Therapy
  • Countries : Europe
NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025

NORTH AMERICA STEM CELL ASSAY MARKET FORECAST 2017-2025

  • € 1755
  • Industry report
  • March 2017
  • by Inkwood Research

KEY FINDINGS The North America stem cell assay market is expected to grow $1082 million by 2025. The market growth is expected at the CAGR of 21.69% in the forecast period. The base year considered fo ...

  • Industries : Biological Therapy
  • Countries : North America
Skin Cancer Treatment Drugs Industry Forecasts - China Focus

Skin Cancer Treatment Drugs Industry Forecasts - China Focus

  • € 1636
  • Industry report
  • April 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Cancer, Therapy, Pathology, Oncology
  • Countries : China
Therapy Industry Forecasts - China Focus

Therapy Industry Forecasts - China Focus

  • € 1636
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Therapy industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising ...

  • Industries : Healthcare
  • Countries : China
2017-2021  US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2017-2021 US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • € 1318
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • € 1318
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast - 2017

Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Alfa-2B worldwide and by countries in North America, Europe, ...

  • Industries : Biological Therapy
  • Countries : World
Interferon Beta-1A Sales, Price Analysis, & Sales Forecast - 2017

Interferon Beta-1A Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Interferon Beta-1A Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1A worldwide and by countries in North America, Europe, ...

  • Industries : Biological Therapy
  • Countries : World
Interferon Beta-1B Sales, Price Analysis, & Sales Forecast - 2017

Interferon Beta-1B Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Interferon Beta-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1B worldwide and by countries in North America, Europe, ...

  • Industries : Biological Therapy
  • Countries : World
Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast - 2017

Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Gamma-1B worldwide and by countries in North America, ...

  • Industries : Biological Therapy
  • Countries : World
Filgrastim Sales, Price Analysis, & Sales Forecast - 2017

Filgrastim Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Filgrastim Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Filgrastim worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biological Therapy
  • Countries : World
Imiquimod Sales, Price Analysis, & Sales Forecast - 2017

Imiquimod Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Imiquimod Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Imiquimod worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biological Therapy
  • Countries : World
Sargramostim Sales, Price Analysis, & Sales Forecast - 2017

Sargramostim Sales, Price Analysis, & Sales Forecast - 2017

  • € 1000
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Sargramostim Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Sargramostim worldwide and by countries in North America, Europe, Japan, ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy Catapult Ltd - Medical Equipment - Deals and Alliances Profile

Cell Therapy Catapult Ltd - Medical Equipment - Deals and Alliances Profile

  • € 227
  • Company report
  • April 2017
  • by GlobalData

Summary Cell Therapy Catapult Ltd (Catapult) is a developer of cell and gene therapies. The company supports cell and gene therapy companies worldwide to translate early stage research into commercially ...

  • Industries : Biological Therapy
  • Countries : United Kingdom
U.S. Stem Cell Inc (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

U.S. Stem Cell Inc (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary U.S. Stem cell Inc (U.S. Stem cell), formerly Bioheart, Inc, is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The ...

  • Industries : Biological Therapy
  • Countries : United States
Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Harvard Stem Cell Institute (HSCI), a part of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments ...

Genenta Science srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genenta Science srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Genenta Science srl (Geneta Science) is a biotechnology company which develops new generation of gene therapies based on transcriptional and mirRNA-mediated control. The company develops gene transfe ...

  • Industries : Biological Therapy
International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary International Stem Cell Corp (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the field ...

  • Industries : Biological Therapy
Janus Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Janus Biotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Janus Biotherapeutics Inc (Janus Biotherapeutics) develops therapies for the treatment of autoimmune diseases. The company develops oral compounds that aim to stop the abnormal toll-like recepto ...

Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated ...

  • Industries : Biological Therapy, Cancer, Pathology
Atara Biotherapeutics Inc (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Atara Biotherapeutics Inc (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Atara Biotherapeutics Inc (Atara) is a clinical-stage biopharmaceutical company that develops therapies for medical needs. The company develops drugs for muscle wasting conditions and cancer. Its ...

  • Industries : Biological Therapy, Healthcare
  • Countries : United States
Cell Therapy Catapult Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Therapy Catapult Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • March 2017
  • by GlobalData

Summary Cell Therapy Catapult Ltd(Catapult), d/b/a Cell and Gene Therapy Catapult, is a biotechnology company that develops, delivers and commercializes cell and gene therapies. The company helps cell ...

  • Industries : Biological Therapy
  • Countries : United Kingdom

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.